Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Leukemia, Myeloid, Acute 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Myelodysplastic Syndromes 12Lymphoma, Non-Hodgkin 11Hodgkin Disease 11Leukemia, Lymphocytic, Chronic, B-Cell 10Leukemia 10Multiple Myeloma 9Leukemia, Myelomonocytic, Chronic 9Leukemia, Myeloid, Accelerated Phase 9Lymphoma, Mantle-Cell 8Leukemia, Myeloid, Chronic-Phase 8Hematologic Neoplasms 8Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Lymphoma 7Myeloproliferative Disorders 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Biphenotypic, Acute 6Graft vs Host Disease 6Congenital Abnormalities 6Blast Crisis 6Waldenstrom Macroglobulinemia 5Lymphoma, Large-Cell, Immunoblastic 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Carcinoma, Renal Cell 5Burkitt Lymphoma 5Anemia, Refractory, with Excess of Blasts 5Lymphoma, T-Cell, Cutaneous 4Recurrence 3

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Stem Cell Transplantation 1Sirolimus 1Mycophenolic Acid 1Hematopoietic Stem Cell Transplantation 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Non-Malignant Neoplasm × Mycophenolic Acid × Clear all
NCT04083183 2025-12-18

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
40 enrolled
Other neoplasm

Non-Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡